hamster antimouse tnf-α Search Results


90
Becton Dickinson monoclonal hamster anti-mouse tumor necrosis factor (tnf)-α antibody
Monoclonal Hamster Anti Mouse Tumor Necrosis Factor (Tnf) α Antibody, supplied by Becton Dickinson, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/hamster+antimouse+tnf-%CE%B1/pmc02684178-135-1-9?v=Becton+Dickinson
Average 90 stars, based on 1 article reviews
monoclonal hamster anti-mouse tumor necrosis factor (tnf)-α antibody - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
Becton Dickinson 1 µg/5 µl phycoerythrin hamster anti-mouse tnf receptor (tnfr) type ii (p75) monoclonal antibody
1 µg/5 µl Phycoerythrin Hamster Anti Mouse Tnf Receptor (Tnfr) Type Ii (P75) Monoclonal Antibody, supplied by Becton Dickinson, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/hamster+antimouse+tnf-%CE%B1/pmc03741566-42-20-31?v=Becton+Dickinson
Average 90 stars, based on 1 article reviews
1 µg/5 µl phycoerythrin hamster anti-mouse tnf receptor (tnfr) type ii (p75) monoclonal antibody - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
Becton Dickinson purified na/le hamster anti-mouse/rat tnf
A. The maternal effect on offspring phenotypes is postnatal. (a,b) Association of the postnatal <t>TNF</t> deficient maternal environment with enhanced cognitive performance in MWM (Two way ANOVA; platform location left : F 3,124 =21.70, P <10 −5 , N= 12,6,12,5/group; platform location right : F 3,48 =26.050, P =0.0001 and location x group F 3,38 =3.78, P =0.016, N=8,6; LSD posthoc. *p<0.05; ***<0.0005) and fear conditioning (ANOVA: F 2, 21 =4.32, P=0.03; LSD posthoc *p<0.05; N= 6,7,10). Data are shown as means ± SE. (c) Association of the postnatal TNF deficient maternal environment with increased proliferation in P14 DG (ANOVA: F 2,16 =6.3, P =0.01; N= 6,7,6; LSD posthoc. *p<0.05). ( <t>d)</t> <t>Postpartum</t> administration of infliximab increases P14 DG proliferation in the offspring (t-test, T=2.709 p=0.014, N=14,6). Data are from two independent experiments. Box-whisker plots represent the first three quartiles (25%, median and 75%) and values 1.5× the interquartile range below the first quartile (lower horizontal line) and above the third quartile (upper horizontal line). ( e) Offspring of infliximab and anti-mouse TNF antibody treated mothers had a higher level of recall of the platform location in probe trial 1 than that of the control offspring (Two way ANOVA; quadrant: F 3,132 =35.93, P <10 −5 ; group x quadrant: F 6,132 =2.14, P =0.05; N=16,9,11/group; LSD posthoc. *p<0.05; ***p<0.0005). Controls, derived from mothers injected postnatally with either BSA or IgG1 isotype control antibodies, were pooled as their behavior did not differ.
Purified Na/Le Hamster Anti Mouse/Rat Tnf, supplied by Becton Dickinson, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/hamster+antimouse+tnf-%CE%B1/pmc06169993-167-8-10?v=Becton+Dickinson
Average 90 stars, based on 1 article reviews
purified na/le hamster anti-mouse/rat tnf - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier





Image Search Results


A. The maternal effect on offspring phenotypes is postnatal. (a,b) Association of the postnatal TNF deficient maternal environment with enhanced cognitive performance in MWM (Two way ANOVA; platform location left : F 3,124 =21.70, P <10 −5 , N= 12,6,12,5/group; platform location right : F 3,48 =26.050, P =0.0001 and location x group F 3,38 =3.78, P =0.016, N=8,6; LSD posthoc. *p<0.05; ***<0.0005) and fear conditioning (ANOVA: F 2, 21 =4.32, P=0.03; LSD posthoc *p<0.05; N= 6,7,10). Data are shown as means ± SE. (c) Association of the postnatal TNF deficient maternal environment with increased proliferation in P14 DG (ANOVA: F 2,16 =6.3, P =0.01; N= 6,7,6; LSD posthoc. *p<0.05). ( d) Postpartum administration of infliximab increases P14 DG proliferation in the offspring (t-test, T=2.709 p=0.014, N=14,6). Data are from two independent experiments. Box-whisker plots represent the first three quartiles (25%, median and 75%) and values 1.5× the interquartile range below the first quartile (lower horizontal line) and above the third quartile (upper horizontal line). ( e) Offspring of infliximab and anti-mouse TNF antibody treated mothers had a higher level of recall of the platform location in probe trial 1 than that of the control offspring (Two way ANOVA; quadrant: F 3,132 =35.93, P <10 −5 ; group x quadrant: F 6,132 =2.14, P =0.05; N=16,9,11/group; LSD posthoc. *p<0.05; ***p<0.0005). Controls, derived from mothers injected postnatally with either BSA or IgG1 isotype control antibodies, were pooled as their behavior did not differ.

Journal: Nature neuroscience

Article Title: Maternal hematopoietic TNF, via milk chemokines, programs hippocampal development and memory

doi: 10.1038/nn.3596

Figure Lengend Snippet: A. The maternal effect on offspring phenotypes is postnatal. (a,b) Association of the postnatal TNF deficient maternal environment with enhanced cognitive performance in MWM (Two way ANOVA; platform location left : F 3,124 =21.70, P <10 −5 , N= 12,6,12,5/group; platform location right : F 3,48 =26.050, P =0.0001 and location x group F 3,38 =3.78, P =0.016, N=8,6; LSD posthoc. *p<0.05; ***<0.0005) and fear conditioning (ANOVA: F 2, 21 =4.32, P=0.03; LSD posthoc *p<0.05; N= 6,7,10). Data are shown as means ± SE. (c) Association of the postnatal TNF deficient maternal environment with increased proliferation in P14 DG (ANOVA: F 2,16 =6.3, P =0.01; N= 6,7,6; LSD posthoc. *p<0.05). ( d) Postpartum administration of infliximab increases P14 DG proliferation in the offspring (t-test, T=2.709 p=0.014, N=14,6). Data are from two independent experiments. Box-whisker plots represent the first three quartiles (25%, median and 75%) and values 1.5× the interquartile range below the first quartile (lower horizontal line) and above the third quartile (upper horizontal line). ( e) Offspring of infliximab and anti-mouse TNF antibody treated mothers had a higher level of recall of the platform location in probe trial 1 than that of the control offspring (Two way ANOVA; quadrant: F 3,132 =35.93, P <10 −5 ; group x quadrant: F 6,132 =2.14, P =0.05; N=16,9,11/group; LSD posthoc. *p<0.05; ***p<0.0005). Controls, derived from mothers injected postnatally with either BSA or IgG1 isotype control antibodies, were pooled as their behavior did not differ.

Article Snippet: Another group of mice received purified NA/LE hamster anti-mouse/rat TNF (BD Pharmingen 557370), 300μg/mice, at postpartum day 1, 7 and 14.

Techniques: Whisker Assay, Derivative Assay, Injection

Reduced milk chemokine levels in TNF deficient mothers are responsible for the WT(H) phenotypes. (a) Chemokine levels in postpartum day2 milk of TNF TNF +/− and TNF −/− mothers (two way ANOVA; genotype effect: F 2,110 =26.40, P <0.0001; group x chemokine: F 20,110 =4.31, P <0.0001; Tukey HSD posthoc test *p<0.05; N=5,3,5/group). Data are shown as means ± SE. (b) A cocktail of 5 recombinant cytokines at 3x and 10x doses given by gavage daily (1x: IP-10, 4 pg/g mouse weight; MIP-1β, 25pg/g; MCP-1, 10pg/g; MCP-3, 4 pg/g, and MCP-5, 0.7 pg/g) between P1 and P14 reduced proliferation in P14 DG (ANOVA; F 3,118 =4.14, P =0.021; N=5,6,6,5/group, LSD posthoc. *p<0.05, #<0.1). (c) The cytokine cocktails given between P1 and P21 reduced adult MWM memory in probe trial 1 at the 3x and 10x doses (Two way ANOVA; platform location: F 3,75 =24.98, P <10 −5 ; group x platform location: F 6,75 =2.60, P =0.024; N=8,5,7,9/group, LSD posthoc. *p<0.05; ***<0.0005). (d) Increased WBC counts ( t -test, T=2.678, p=0.019), due to elevated levels of lymphocyte and monocyte numbers in P10 pup of TNF +/− mothers as compared to pups of WT mothers (Manual count; Two way ANOVA, group: F 1,65 =9.37, P =0.0003; N=6,9/group, LSD posthoc. *p<0.05; **<0.005). Because the WT and KO pups of H mothers were not different, data were combined. NEUT, neutrophil; LYMPH, lymphocyte; MONO, monocyte; EOS, eosinophil; BASO, basophil.

Journal: Nature neuroscience

Article Title: Maternal hematopoietic TNF, via milk chemokines, programs hippocampal development and memory

doi: 10.1038/nn.3596

Figure Lengend Snippet: Reduced milk chemokine levels in TNF deficient mothers are responsible for the WT(H) phenotypes. (a) Chemokine levels in postpartum day2 milk of TNF TNF +/− and TNF −/− mothers (two way ANOVA; genotype effect: F 2,110 =26.40, P <0.0001; group x chemokine: F 20,110 =4.31, P <0.0001; Tukey HSD posthoc test *p<0.05; N=5,3,5/group). Data are shown as means ± SE. (b) A cocktail of 5 recombinant cytokines at 3x and 10x doses given by gavage daily (1x: IP-10, 4 pg/g mouse weight; MIP-1β, 25pg/g; MCP-1, 10pg/g; MCP-3, 4 pg/g, and MCP-5, 0.7 pg/g) between P1 and P14 reduced proliferation in P14 DG (ANOVA; F 3,118 =4.14, P =0.021; N=5,6,6,5/group, LSD posthoc. *p<0.05, #<0.1). (c) The cytokine cocktails given between P1 and P21 reduced adult MWM memory in probe trial 1 at the 3x and 10x doses (Two way ANOVA; platform location: F 3,75 =24.98, P <10 −5 ; group x platform location: F 6,75 =2.60, P =0.024; N=8,5,7,9/group, LSD posthoc. *p<0.05; ***<0.0005). (d) Increased WBC counts ( t -test, T=2.678, p=0.019), due to elevated levels of lymphocyte and monocyte numbers in P10 pup of TNF +/− mothers as compared to pups of WT mothers (Manual count; Two way ANOVA, group: F 1,65 =9.37, P =0.0003; N=6,9/group, LSD posthoc. *p<0.05; **<0.005). Because the WT and KO pups of H mothers were not different, data were combined. NEUT, neutrophil; LYMPH, lymphocyte; MONO, monocyte; EOS, eosinophil; BASO, basophil.

Article Snippet: Another group of mice received purified NA/LE hamster anti-mouse/rat TNF (BD Pharmingen 557370), 300μg/mice, at postpartum day 1, 7 and 14.

Techniques: Recombinant